Head-to-head · Value Score
Vitara RX vs NewSelf
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, NewSelf a 87. Here's what each one really costs past month one — and where each one bites back.
Vitara RX
Grade A · Excellent
Advertised price
$99/mo
Save ~72% vs brand self-pay
NewSelf
Grade A- · Great Deal
Advertised price
$134.99/mo at every dose
$134.99/mo at every dose (as low as $99.97 on a longer plan)
Save ~61% vs brand self-payThe verdict
Vitara RX takes it on Value Score, 91 to 87 — an est. $99/mo first month, with no teaser step-up baked in. NewSelf isn't out of it: Someone who expects to titrate high and wants the price to stay where it started.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | NewSelf |
|---|---|---|
| Value Score | 91 (A) | 87 (A-) |
| Advertised price | $99/mo | $134.99/mo at every dose (as low as $99.97 on a longer plan) |
| Save vs brand self-pay | ~72% | ~61% |
| Semaglutide | $99/mo | $134.99/mo at every dose (as low as $99.97 on a longer plan) |
| Tirzepatide | $149/mo | $224.99/mo at every dose (as low as $144.49 on a longer plan) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | 49 states | 49 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
NewSelf
NewSelf sells compounded semaglutide with B12 or glycine at $134.99 a month and compounded tirzepatide with B6 and glycine at $224.99, both held flat across every dose, in 49 states.
Why it's a deal
- The rate holds at every dose on both molecules — semaglutide across 0.25 mg to 2.5 mg, tirzepatide across 2.5 mg to 15 mg — so titrating up costs nothing extra
- Both products are compounded with B12, B6 or glycine rather than sold as bare molecules, and the formulation is stated on the product card
- HSA and FSA eligible, with the health screening, shipping and ongoing support inside the price
- Names the 49 states it covers rather than implying nationwide reach
The fine print
- The prominent $99.97 and $144.49 figures are plan floors, not the standing rates — those are $134.99 and $224.99
- Not available in Mississippi or Louisiana
- A "Tirzepatide Plus" tier at $399 a month sits above the standard product, so the flat-rate promise applies within a tier rather than across the range
- Compounded only — no FDA-approved brand-name route
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives ranking, and the same list for the other side is on alternatives to NewSelf.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.